OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 45
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Chronic inflammation and the hallmarks of aging
Jordan J. Baechle, Nan Chen, Priya Makhijani, et al.
Molecular Metabolism (2023) Vol. 74, pp. 101755-101755
Open Access | Times Cited: 126
Jordan J. Baechle, Nan Chen, Priya Makhijani, et al.
Molecular Metabolism (2023) Vol. 74, pp. 101755-101755
Open Access | Times Cited: 126
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 51
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 51
Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and iron
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 51
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 51
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 37
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 37
Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
Mengru Liu, Siqi Liu, Zi-Han Lin, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 1
Mengru Liu, Siqi Liu, Zi-Han Lin, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 1
Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration
Stanisław Szlufik, Kamila Kopeć, Stanisław Szleszkowski, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 286-286
Open Access | Times Cited: 12
Stanisław Szlufik, Kamila Kopeć, Stanisław Szleszkowski, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 286-286
Open Access | Times Cited: 12
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders
Sydney Risen, Sean W. Boland, Sadhana Sharma, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1533-1547
Closed Access | Times Cited: 11
Sydney Risen, Sean W. Boland, Sadhana Sharma, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1533-1547
Closed Access | Times Cited: 11
The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review
Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4130-4130
Open Access | Times Cited: 11
Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4130-4130
Open Access | Times Cited: 11
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson’s disease models and patients
Yi Zhuo, Wenshui Li, Wen Quan Lu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Yi Zhuo, Wenshui Li, Wen Quan Lu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 5
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 5
Glial cells improve Parkinson’s disease by modulating neuronal function and regulating neuronal ferroptosis
Mengzhu Li, Mengxuan Chen, Haiyan Li, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Mengzhu Li, Mengxuan Chen, Haiyan Li, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases
Yujie Sun, Qiankun Lv, Junyi Liu, et al.
Neurobiology of Disease (2025) Vol. 205, pp. 106791-106791
Open Access
Yujie Sun, Qiankun Lv, Junyi Liu, et al.
Neurobiology of Disease (2025) Vol. 205, pp. 106791-106791
Open Access
Potential common targets of music therapy intervention in neuropsychiatric disorders: the prefrontal cortex-hippocampus -amygdala circuit (a review)
Yang Dan, Ying Xiong, Danghan Xu, et al.
Frontiers in Human Neuroscience (2025) Vol. 19
Open Access
Yang Dan, Ying Xiong, Danghan Xu, et al.
Frontiers in Human Neuroscience (2025) Vol. 19
Open Access
Irisin promotes autophagy and attenuates NLRP3 inflammasome activation in Parkinson’s disease
Min Zhu, Qinyu Peng, Sheng Li, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114201-114201
Closed Access
Min Zhu, Qinyu Peng, Sheng Li, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114201-114201
Closed Access
Microglia toxicology in α-synuclein pathology
Han Zhang, Jieli Zhang, Xiuna Jing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167727-167727
Closed Access
Han Zhang, Jieli Zhang, Xiuna Jing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167727-167727
Closed Access
Plasma Metabolites as Mediators Between Gut Microbiota and Parkinson’s Disease: Insights from Mendelian Randomization
Jianzhun Chen, Liuhui Zhu, Fang Wang, et al.
Molecular Neurobiology (2025)
Closed Access
Jianzhun Chen, Liuhui Zhu, Fang Wang, et al.
Molecular Neurobiology (2025)
Closed Access
The 5-HT1F Receptor Agonist Lasmiditan improves Cognition and Ameliorates Associated Cortico-Hippocampal Pathology in Aging Parkinsonian Mice
Atsushi Ishii, J. Wayne Meredith, Mandi J. Corenblum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Atsushi Ishii, J. Wayne Meredith, Mandi J. Corenblum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Chitinase Signature in the Plasticity of Neurodegenerative Diseases
Cristina Russo, Maria Stella Valle, Antonino Casabona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6301-6301
Open Access | Times Cited: 12
Cristina Russo, Maria Stella Valle, Antonino Casabona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6301-6301
Open Access | Times Cited: 12
Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
Carmela Conte, Angela Ingrassia, John J. P. Brevé, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1368-1368
Open Access | Times Cited: 12
Carmela Conte, Angela Ingrassia, John J. P. Brevé, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1368-1368
Open Access | Times Cited: 12
Polarization to M1-type microglia in the hippocampus is involved in depression-like behavior in a mouse model of olfactory dysfunction
Kohei Takahashi, Minoru Tsuji, Osamu Nakagawasai, et al.
Neurochemistry International (2024) Vol. 175, pp. 105723-105723
Closed Access | Times Cited: 3
Kohei Takahashi, Minoru Tsuji, Osamu Nakagawasai, et al.
Neurochemistry International (2024) Vol. 175, pp. 105723-105723
Closed Access | Times Cited: 3
Biomarkers in neurodegenerative diseases: a broad overview
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 3
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 3
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henrı́quez, Mahesh Narayan
Exploration of Neuroprotective Therapy (2023), pp. 207-234
Open Access | Times Cited: 8
Gabriela Henrı́quez, Mahesh Narayan
Exploration of Neuroprotective Therapy (2023), pp. 207-234
Open Access | Times Cited: 8
DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson’s disease
Thomas Müller
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 787-792
Closed Access | Times Cited: 5
Thomas Müller
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 787-792
Closed Access | Times Cited: 5
